---
title: "JBM Healthcare and Jacobson Pharma Renew Connected Logistics Framework Through 2029"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/278105143.md"
description: "JBM Healthcare and Jacobson Pharma Renew Connected Logistics Framework Through 2029"
datetime: "2026-03-06T13:11:25.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/278105143.md)
  - [en](https://longbridge.com/en/news/278105143.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/278105143.md)
---

# JBM Healthcare and Jacobson Pharma Renew Connected Logistics Framework Through 2029

JBM Healthcare and Jacobson Pharma Renew Connected Logistics Framework Through 2029

### Related Stocks

- [512290.CN](https://longbridge.com/en/quote/512290.CN.md)
- [589720.CN](https://longbridge.com/en/quote/589720.CN.md)
- [513700.CN](https://longbridge.com/en/quote/513700.CN.md)
- [159316.CN](https://longbridge.com/en/quote/159316.CN.md)
- [02633.HK](https://longbridge.com/en/quote/02633.HK.md)
- [510660.CN](https://longbridge.com/en/quote/510660.CN.md)
- [588130.CN](https://longbridge.com/en/quote/588130.CN.md)
- [159992.CN](https://longbridge.com/en/quote/159992.CN.md)
- [512010.CN](https://longbridge.com/en/quote/512010.CN.md)
- [159898.CN](https://longbridge.com/en/quote/159898.CN.md)
- [520690.CN](https://longbridge.com/en/quote/520690.CN.md)
- [520880.CN](https://longbridge.com/en/quote/520880.CN.md)
- [159929.CN](https://longbridge.com/en/quote/159929.CN.md)

## Related News & Research

- [Flow Pharma U.S. Patent Application Allowed for Issuance Covering Broad-Spectrum Ebola Therapy](https://longbridge.com/en/news/287076761.md)
- [Analyst Reiterates Buy on Microbix, Citing Temporary China Slowdown and Growing Diversified Demand](https://longbridge.com/en/news/286665358.md)
- [Broncus shareholders back all AGM resolutions, update articles of association](https://longbridge.com/en/news/286439966.md)
- [Everest Medicines Director and Major Shareholder Raises Stake in Company](https://longbridge.com/en/news/286481551.md)
- [20:03 ETHarbour BioMed Announces Promising Preclinical Data for LET003, Its First AI-Enabled Drug Candidate](https://longbridge.com/en/news/286688082.md)